Every enterprise racing to train or deploy AI agents runs into the same wall: the data they need is also the data they can't legally share. Healthcare and pharmaceutical companies sit on some of the most valuable training data in the world, and some of the most dangerous to expose.

As more organisations pull back from feeding proprietary or personal information into AI models, a new category of problem has opened up: how do you get AI-ready without breaking privacy law, patient trust, or internal policy?

Integral solves exactly that. It evaluates data to confirm it's properly de-identified, and where it isn't, it remediates or synthetically replaces the sensitive parts so the data becomes safe to use. What Integral needed was a way to explain it that didn't read like a compliance manual.

De-identification isn't a new idea, but de-identification for AI training is a category most buyers don't know exists yet. Integral's challenge wasn't just explaining a product. It was educating a market on a problem it hadn't fully named, while positioning Integral as the company that already has the answer.

That split defined the brief from the start: roughly a quarter of the video's job was education, the rest was making Integral feel like the obvious enabler once the problem clicked.

The data itself became the main character. A single shape that moves through the systems it has to pass through, exposed at every step, until it hits the real dilemma: strip the signal out, or leave it exposed. Most data never survives that choice. It gets left behind.

That's the tension "privacy is integral" resolves, and we held the line back until the audience had felt the problem. Once Integral's platform appears, the same data returns transformed, signal preserved, risk assessed, built to be examined.

We then wanted to pull back in scale, from infrastructure to a globe of frontier AI pipelines, then down to individuals, real people, not just enterprise data.